Comments to FDA: External Analgesic Drug Products for OTC Human Use Share page: Docket Number: 78N-0301 In this submission the task group provides updated data on the safety of counterirritants administered via patched or other novel dosage forms. Download Document Issues: OTC Medicines Related Posts Comments Comments Regarding Control of Nitrosamine Impurities in Human Drugs Dec 20, 2024 Press Releases and Statements Rates for Teen Abuse of OTC Cough/Cold Medication Remains Low According to NIDA Survey Dec 18, 2024 Pediatric Cough/Cold Dosing